Royce & Associates’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
+380,997
| New | +$5.64M | 0.06% | 433 |
|
|
2024
Q3 | – | Sell |
-47,573
| Closed | -$391K | – | 909 |
|
|
2024
Q2 | $391K | Hold |
47,573
| – | – | ﹤0.01% | 806 |
|
|
2024
Q1 | $367K | Buy |
47,573
+5,932
| +14% | +$45.7K | ﹤0.01% | 809 |
|
|
2023
Q4 | $374K | Buy |
41,641
+23,302
| +127% | +$209K | ﹤0.01% | 808 |
|
|
2023
Q3 | $164K | Buy |
+18,339
| New | +$164K | ﹤0.01% | 884 |
|